4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/(-)-Epigallocatechin gallate/AG-CN2-0063-M100/100 mg
商品详细Adipogen/(-)-Epigallocatechin gallate/AG-CN2-0063-M100/100 mg
Adipogen/(-)-Epigallocatechin gallate/AG-CN2-0063-M100/100 mg
Adipogen/(-)-Epigallocatechin gallate/AG-CN2-0063-M100/100 mg
商品编号: AG-CN2-0063-M100
品牌: Adipogen Inc
市场价: ¥1800.00
美元价: 1080.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsEpigallocatechin-3-gallate;EGCG;CCRIS3729;Teavigo;NVP-XAA723
ProductTypeChemical
Properties
FormulaC22H18O11
MW458.4
MerckIndex14:3526
CAS989-51-5
RTECSKB5200000
Source/HostChemicalsIsolatedfromgreentea.
PurityChemicals≥98%(HPLC)
AppearanceOff-whitetowhitepowder.
SolubilitySolubleinDMSO,ethanol,dimethylformamideandwater.
IdentityDeterminedby1H-NMRandMS.
InChiKeyWMBWREPUVVBILR-WIYYLYMNSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
HandlingAdviceKeepcoolanddry.
Keepunderinertgas.
Protectfromlight.
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat-20°C.
Afterreconstitution,preparealiquotsandstoreat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Potentanticancercompound.
  • Anti-angiogenic.VEGF,VE-cadherinphosphorylation,matrixmetalloproteinaseandurokinase-plasminogenactivator(uPA)inhibitor.
  • Anti-inflammatory.NF-κBinhibitor.Modulateschronicinflammatorydiseases,suchastype2diabetes,rheumatoidarthritis,inflammatoryboweldisease.
  • COX-2andinducIBLenitricoxidesynthase(iNOS;NOSII)inhibitor.
  • Potentantioxidant.ProtectscellsfromlipidperoxidationandDNAdamageinducedbyreactivefreerADIcals.
  • Regulatescancercellgrowth,proliferation,transformation,survival,angiogenesis,apoptosis,invasionandmetastasis.
  • Chemopreventive.Apoptosisinducer.Promotescellcyclearrest.
  • ModulatessignaltransductionpathwaysincludingJAK/STAT,MAPK,PI3K/AKT,WntandNotch.
  • EGFRandHER-2receptorsignalinginhibitor.
  • MAPKsandactivatorprotein-1inhibitor.
  • PotentDYRK1Ainhibitor(IC50=330nM).
  • mTORsuppressor.
  • IGF-Isignalinginhibitor.
  • Proteasomeinhibitor.
  • TelomeraseandDNAmethyltransferaseinhibitor.
  • SelectiveandnoncompetitiveHATinhibitor. 
  • TopoisomeraseIandIIinhibitor.
  • Hedgehogsignaling(Hh)modulator.PTCHandGli1inhibitor.
  • Wntsignalinginhibitor.
  • Neuroprotective.ActivatesHO-1bytheARE/Nrf2pathway,protectingneuronsagainstoxidativedamage.
  • STAT-1inhibitor.
  • Showspreventivecardiovascularandmetabolic(obesity,insulinresistance,hypertensionandhypercholesterolemia)effects.
  • Inhibitsextracellularsignal-relatedkinases(ERK),activatesAMP-activatedproteinkinase(AMPK),modulatesadipocyteMarkerproteinsanddown-regulateslipogenicenzymesaswellasotherpotentialtargets.
  • Fattyacidsynthase(FAS)inhibitor.
  • Autophagystimulator.
ProductReferences
  1. Molecularmechanismsunderlyingchemopreventiveactivitiesofanti-inflammatoryphytochemicals:down-regulationofCOX-2andiNOSthroughsuppressionofNF-kappaBactivation:Y.J.Surh,etal.;Mutat.Res.480-481,243(2001)(Review)
  2. Thespecificitiesofproteinkinaseinhibitors:anupdate:J.Bain,etal.;Biochem.J.371,199(2003)
  3. Targetingmultiplesignalingpathwaysbygreenteapolyphenol(-)-epigallocatechin-3-gallate:N.Khan,etal.;CancerRes.66,2500(2006)(Review)
  4. Inhibitionoffattyacidsynthasebypolyphenols:W.X.Tian;Curr.Med.Chem.13,967(2006)(Review)
  5. Greenteapolyphenolsasanaturaltumourcellproteasomeinhibitor:Q.P.Dou,etal.;Inflammopharmacology16,208(2008)(Review)
  6. Chemopreventionwithphytochemicalstargetinginduciblenitricoxidesynthase:A.Murakami;ForumNutr.61,193(2009)(Review)
  7. MolecularbasisforcancerchemopreventionbygreenteapolyphenolEGCG:H.Tachibana;ForumNutr.61,156(2009)(Review)
  8. Apoptosisbydietaryagentsforpreventionandtreatmentofprostatecancer:N.Khan,etal.;Endocr.Relat.Cancer17,R39(2010)(Review)
  9. Targetingpolyaminesandbiogenicaminesbygreenteaepigallocatechin-3-gallate:E.Melgarejo,etal.;AminoAcids38,519(2010)(Review)
  10. Greenteapolyphenolepigallocatechin-3-gallate:inflammationandarthritis:R.Singh,etal.;LifeSci.86,907(2010)(Review)
  11. Regulationofsurvival,proliferation,invasion,angiogenesis,andmetastasisoftumorcellsthroughmodulationofinflammatorypathwaysbynutraceuticals:S.C.Gupta,etal.;CancerMetastasisRev.29,405(2010)(Review)
  12. UpdatesofmTORinhibitors:H.Zhou,etal.;AnticancerAgentsMed.Chem.10,571(2010)(Review)
  13. TheroleofnutraceuticalsintheregulationofWntandHedgehogsignalingincancer:F.H.Sarkar,etal.;CancerMetastasisRev.29,383(2010)(Review)
  14. UseofSTAT1inhibitorsinthetreatmentofbrainI/Rinjuryandneurodegenerativediseases:F.H.Ebner,etal.;Cent.Nerv.Syst.AgentsMed.Chem.11,2(2011)(Review)
  15. Weightcontrolandpreventionofmetabolicsyndromebygreentea:S.Sae-tan,etal.;Pharmacol.Res.64,146(2011)(Review)
  16. Targetingcellsignalingandapoptoticpathwaysbydietaryagents:roleinthepreventionandtreatmentofcancer:M.K.Shanmugam,etal.;Nutr.Cancer63,161(2011)(Review)
  17. Implicationsofcancerstemcelltheoryforcancerchemopreventionbynaturaldietarycompounds:Y.Li,etal.;J.Nutr.Biochem.22,799(2011)(Review)
  18. ModulationofNrf2/AREpathwaybyfoodpolyphenols:anutritionalneuroprotectivestrategyforcognitiveandneurodegenerativedisorders:G.Scapagnini,etal.;Mol.Neurobiol.44,192(2011)(Review)
  19. NutritionalapproachestomodulateoxidativestressinAlzheimer"sdisease:C.B.Pocernich,etal.;Curr.AlzheimerRes.8,452(2011)(Review)
  20. Possibleinvolvementofprogrammedcelldeathpathwaysintheneuroprotectiveactionofpolyphenols:S.Bastianetto,etal.;Curr.AlzheimerRes.8,445(2011)(Review)
  21. Greenteacatechin,epigallocatechin-3-gallate(EGCG):mechanisms,perspectivesandclinicalapplications:B.N.Singh,etal.;Biochem.Pharmacol.82,1807(2011)(Review)
  22. Epigeneticdiet:impactontheepigenomeandcancer:T.M. Hardy&T.O.Tollefsbol;Epigenomics3,503(2011)(Review)
  23. GreenteaEGCG,Tcells,andTcell-mediatedautoimmunediseases:D.Wu,etal.;Mol.AspectsMed33,107(2012)(Review)
  24. Epigallocatechin-3-gallate,aDYRK1Ainhibitor,rescuescognitivedeficitsinDownsyndromemousemodelsandinhumans:R.DelaTorre,etal.;Mol.Nutr.FoodRes.58,278(2014)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。